Shared on 03 Sep 25

Fair value Increased 2.23%

Analysts have raised Sabra Health Care REIT’s price target to $20.82, citing strong portfolio performance—highlighted by robust senior housing NOI growth, increased rent coverage, and supportive reimbursement trends—despite elevated leverage and valuation constraints. Analyst Commentary Strong balance sheet and solid year-to-date stock performance, though leverage remains higher than some peers and valuation is at the upper end of historical range, limiting immediate earnings accretion from new acquisitions.

Read more

0 votesShare

Shared on 08 May 25

Fair value Increased 2.02%

Read more

0 votesShare

Shared on 30 Apr 25

Fair value Decreased 0.05%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

0 votesShare

Shared on 23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

0 votesShare

Shared on 17 Apr 25

Fair value Decreased 0.84%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

0 votesShare

Shared on 09 Apr 25

AnalystConsensusTarget has decreased discount rate from 8.1% to 7.3%.

Read more

0 votesShare

Shared on 02 Apr 25

Fair value Increased 2.49%

AnalystConsensusTarget has increased revenue growth from 4.1% to 5.3%.

Read more

0 votesShare

Shared on 26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

0 votesShare

Shared on 19 Mar 25

Fair value Increased 0.46%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

0 votesShare

Shared on 11 Mar 25

Fair value Decreased 1.30%

AnalystConsensusTarget has decreased revenue growth from 5.2% to 4.5%.

Read more

0 votesShare